Azelastine
Active ingredient · 3 therapeutic classes
Sold as OPTILAST
- Drug class
- Other Antihistamines For Systemic Use
- Availability
- Prescription only
- Routes
- Nasal, Intraocular
- Markets covered
- 2
- Products on record
- 35
Overview
Azelastine is an active pharmaceutical ingredient in the Other Antihistamines For Systemic Use group (R06AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 32 | May 29, 2026 |
| US United States | FDA | 3 | November 6, 2025 |
GBUnited Kingdom· MHRA
32 products
Uses
Relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.
How to take
USUnited States· FDA
3 products
Uses
1 INDICATIONS AND USAGE Azelastine hydrochloride nasal spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older.
Azelastine hydrochloride nasal spray is an H1-receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older.
( 1 )
How to take
Drug interactions
Known interactions involving Azelastine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 251. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL177801213 · revised March 13, 2026
- [2]FDA DailyMed · 02257284-4bb1-4f… · revised November 6, 2025 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.